21149 ⎘
Medicinal preparations containing antigens or antibodies; Antibodies ; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody
#902TREATMENT METHOD
#903Fully human antibodies directed against the human insulin-like growth factor-1 receptor
#904Enhancing the efficacy of immunotherapies by supplementing with complement
#905Chimeric allgraft tolerance induction, monitoring and maintenance
#906Compositions comprising anti-CCR5 antibody
#907Methods of Therapy for Chronic Lymphocytic Leukemia
#908Treatment with anti-VEGF antibodies
#909Use of a CD40:CD154 binding interruptor to prevent counter-adaptive immune responses, particularly graft rejection
#910Anti-CCR5 antibodies
#911Methods of treating inflammatory and autoimmune diseases with natalizumab
#912Induction of immune tolerance
#913Methods of treating lupus using CD4 antibodies
#914Targeting adenoviral vectors to dendritic cells
#915Methods of treating inflammatory and autoimmune diseases with natalizumab
#916Combination therapy using anti-EGFR antibodies and anti-hormonal agents
#917Anti-CD3 and antigen-specific immunotherapy to treat autoimmunity
#918Suppression of transplant rejection
#919TREATMENT WITH ANTI-VEGF ANTIBODIES
#920TREATMENT WITH ANTI-VEGF ANTIBODIES
#921TREATMENT WITH ANTI-VEGF ANTIBODIES
#922TREATMENT WITH ANTI-VEGF ANTIBODIES
#923CD40-binding activating antibodies
#924Methods of treating chronic pain using compositions that specifically bind cd11d (alpha-d) integrin
#925Compositions and methods including a recombinant human MAB that promotes CNS remyelination
#926TREATMENT WITH ANTI-VEGF ANTIBODIES
#927TREATMENT WITH ANTI-VEGF ANTIBODIES
#928TREATMENT WITH ANTI-VEGF ANTIBODIES
#929Method for generating and selecting antibodies against target protein
#930Method for generating anti-variable region monoclonal antibodies
#931TREATMENT WITH ANTI-VEGF ANTIBODIES
#932TREATMENT WITH ANTI-VEGF ANTIBODIES
#933TREATMENT WITH ANTI-VEGF ANTIBODIES
#934TREATMENT WITH ANTI-VEGF ANTIBODIES
#935TREATMENT WITH ANTI-VEGF ANTIBODIES
#936Methods for reducing viral load in HIV-1-infected patients
#937APO-2L receptor agonist and CPT-11 synergism
#938TREATMENT WITH ANTI-VEGF ANTIBODIES
#939Methods of administering/dosing CD2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory disorders
#940Methods of inhibiting human immunodeficiency virus infection through the administration of synergistic combinations of anti-CCR5 monoclonal antibodies, fusion inhibitors, and CD4-GP120 binding inhibitors
#941Method for treating Sjogren's syndrome
#942Compositions and methods for enhanced dendritic cell maturation and function
#943Immunoregulatory Antibodies and Uses Thereof
#944COMBINATION THERAPY FOR TREATMENT OF AUTOIMMUNE DISEASES USING B- CELL DEPLETING/IMMUNOREGULATORY ANTIBODY COMBINATION
#945Use of CD23 Antagonists for the Treatment of Neoplastic Disorders
#946Use of CD23 Antagonists for the Treatment of Neoplastic Disorders
#947Modulation of NKG2D for treating or preventing solid organ allograft rejection
#948COMBINATION THERAPY FOR TREATMENT OF AUTOIMMUNE DISEASES USING B-CELL DEPLETING/IMMUNOREGULATORY ANTIBODY COMBINATION
#949Treatment of bone disorders
#950Anti-TIRC7 antibodies in therapy of inflammatory diseases
#951Methods for treating lymphomas
#952Method for treating dementia or Alzheimer's disease
#953Inhibition of the CD95 ligand/receptor system for the treatment of neurological disorders and injuries
#954Therapeutic uses of inhibitors of RTP801
#955Inhibition of platelet aggregation
#956Methods and compositions for treating conditions of the eye
#957Therapy-enhancing glucan
#958Immunotherapeutic combination for the treatment of tumors that over-express receptors with tyrosine kinase activity
#959Method of treating CD30 positive lymphomas
#960USE OF CD23 ANTAGONISTS FOR THE TREATMENT OF NEOPLASTIC DISORDERS
#961Therapeutic anti-tirc7 antibodies for use in immune related and other diseases
#962Immunosuppressive combination and its use in the treatment or prophylaxis or insulin-producing cell graft rejection
#963Purified composition of bispecific molecules and methods of production
#964Allogeneic and xenogeneic transplantation
#965Compositions of UCP inhibitors, Fas antibody, a fatty acid metabolism inhibitor and/or a glucose metabolism inhibitor
#966Treatment of refractory cancers using NA+/K+ ATPase inhibitors
#967BLy antagonists and uses thereof
#968Lymphotoxin beta receptor agents in combination with chemotherapeutic agents
#969Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome
#970Methods of treating rheumatoid arthritis with an anti-TNF-alpha antibodies and methotrexate
#971Method of potentiating the therapeutic action of monoclonal and polyclonal antibodies
#972Antibody formulations
#973Treatment of respiratory syncytial virus (RSV) infection
#974Method of treatment using ligand-immunogen conjugates
#975Method for treating Sjogren's syndrome
#976Mutant interleukin-15 polypeptides
#977Treatment of HIV infection
#978Combination treatment for multiple sclerosis
#979Mutant interleukin-15-containing compositions and suppression of an immune response
#980Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
#981Therapy-enhancing glucan
#982Combination treatment for non-hematologic malignancies
#983Pharmaceutical composition comprising FGF18 and IL-1 antagonist and method of use
#984Antibodies to insulin-like growth factor I receptor
#985Method for augmenting B cell depletion
#986Antineoplastic combinations of CCI-779 and rituximab
#987Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function
#988Induction of anti-tumor ctl immunity through in vivo triggering of 4-1bb and/or cd40
#989Anti-IGF-I receptor antibody
#990Method of treating autoimmune diseases with interferon-beta and IL-2R antagonist
#991Antibodies to insulin-like growth factor I receptor
#992Method and composition for altering a B cell mediated pathology
#993Therapeutic transplantation using developing, human or porcine, renal or hepatic, grafts
#994Treatment method
#995Methods for treatment of HIV and other infections using a T cell or viral activator and anti-retroviral combination therapy
#996Method and composition for altering a B cell mediated pathology
#997Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity
#998Method of treating hemolytic disease
#999Treatment with anti-VEGF antibodies
#1000Detection of CD20 in therapy of autoimmune diseases
#1001Anti-IGF-I receptor antibody
#1002Combined use of anti-cytokine antibodies or antagonists and anti-CD20 for treatment of B cell lymphoma
#1003Method of treating hemolytic disease
#1004Combination of anti-EP-CAM antibody with a chemotherapeutic agent
#1005Combination therapy for B cell disorders
#1006Agents for enhancing the immune response
#1007Anti-IGFR1 antibody therapeutic combinations
#1008Method for treatment of tumors using photodynamic therapy
#1009Use of NOTCH pathway interfering agents for treatment of plasma cell disorders
#1010Methods for generating monoclonal antibody against fusion protein containing peptide fragment derived from membrane protein
#1011Treatment of immunological disorders using anti-dc30 antibodies
#1012Generation of hematopoietic chimerism and induction of central tolerance
#1013Death domain containing receptor 4 antibodies and methods
#1014Combination therapy for B cell disorders
#1015Method of administering an antibody
#1016Methods of preventing or treating disorders by administering and integrin alphanubeta3 antagonist in combination with an HMG-CoA reductase inhibitor or a bisphosphonate
#1017Methods and compositions for immunotherapy of B cell involvement in promotion of a disease condition comprising multiple sclerosis
#1018Methods and compositions for treating rheumatoid arthritis
#1019Methods and compositions for treating rheumatoid arthritis
#1020Combination therapy of gamma-interferon and B-cell specific antibodies
#1021Tolerance induction and maintenance in hematopoietic stem cell allografts
#1022Modified protein kinase a-specific oligonucleotides and methods of their use
#1023Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth
#1024ANTI-T CELL IMMUNOTOXIN FUSION PROTEIN AND ITS THERAPEUTIC USE
#1025Transplant tolerance by costimulation blockade and T-cell activation-induced apoptosis
#1026Post-transplantation prophylaxis and treatments for antibody-mediated rejection of solid organ transplant